University of Florida, USA
Philip F. Daniels is a doctoral student in counseling and counselor education, and earning a certificate in gerontology. He has a Masters in professional counseling with a specialization in marriage and family therapy. National and international teaching experiences include college and career planning, drug and alcohol, introduction to counseling theories, lifespan development, group counseling, play therapy with children, introduction to family therapy, advance family therapy, and human rights and social justice. Clinical experiences include working with clients in hospice, memory disorder units, mental health and rehabilitation units, pediatric clinics, and community agencies conducting individual or family counseling. Specific expertise's include clinical practice and counselor education in the following areas: marriage and family therapy, dementia, caregivers of individuals with dementia, death and dying, end-of-life issues, grief and variations e.g. anticipatory & complicated, trauma, LGBT, substance abuse, and transcultural counselor competencies, play therapy, and working with children.
Neurocognitive disorders (NCD) affected approximately 46 million individuals worldwide in 2015. It is estimated that this will double every 20 years with 65.7 million in 2030 and 115.4 million in 2050. Additionally, medicinal non-compliance within the elderly is a major issue due to adverse side effects and neurocognitive disorders. Therefore, there is a need to be aware of different treatment modalities and options to increase the quality of life of the patient. From an interdisciplinary systems approach to nonpharmacological interventions for individuals with neurocognitive disorders, this presentation will provide a current review of the literature and best practices to help an individual with a NCD. Treatment options such as aromatherapy, music, holding, doll, and sand tray will be explored via their benefits and risks, as well as the feasibility. Finally, an integration of the wellness model and medical model will be utilized to view different treatment options for individuals with a NCD.